About Thomas Barton
Thomas Barton is a director at ImmunoGenesis.
Thomas Barton first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Barton in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Barton works with at each company, as listed on that company's latest Form D.
ImmunoGenesis, Inc. · Form D, Jan 15, 2025
MC
Michael Curran
Director
TK
Ted Koutouzis
Director
JB
Jennifer Barlow
Chief Executive Officer and director
RS
Robert Stein
Director
CS
Clifford Stocks
Director